D. Farrukh

3 ta ish

Tashkent Pediatric Medical Institute

1. 75eP Mutational spectrum of KRAS, TP53, BRAF, ERBB2, and POLE in GI malignancies across diverse populations

   Nikhil Ghadyalpatil, Umut Dişel, O. Zilola +15

   MaqolaOAOchiq kirishChromatin Remodeling and CancerESMO Open20250 iqtibos

   ABIABI:AkademIndex/2025.article.008761

2. Abstract 2510: Comprehensive genomic profiling drives precision oncology and expands accessibility to targeted therapies in Uzbek populations

   Zilola Avazovna Olimova, Gowhar Shafi, D. Farrukh +10

   MaqolaCancer Genomics and DiagnosticsCancer Research20260 iqtibos

   ABIABI:AkademIndex/2026.article.010172

3. Abstract 3141: Integrative genomic analysis reveals pharmacogenomic determinants of chemotherapy response

   D. Farrukh, Yashodhara Bhattacharya, Mohan Uttarwar +8

   MaqolaPharmacogenetics and Drug MetabolismCancer Research20260 iqtibos

   ABIABI:AkademIndex/2026.article.010238